Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ovarian Cancer Recurrent × Lenalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 353 Lymphoma, Large B-Cell, Diffuse 84 Leukemia, Lymphocytic, Chronic, B-Cell 76 Lymphoma, Follicular 69 Recurrence 55 Lymphoma 50 Neoplasms, Plasma Cell 48 Lymphoma, Mantle-Cell 45 Lymphoma, B-Cell, Marginal Zone 45 Lymphoma, Non-Hodgkin 39 Leukemia, Myeloid, Acute 30 Leukemia 25 Lymphoma, B-Cell 22 Neoplasms 20 Myelodysplastic Syndromes 20 Waldenstrom Macroglobulinemia 16 Hodgkin Disease 15 Smoldering Multiple Myeloma 14 Burkitt Lymphoma 13 Prostatic Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, T-Cell, Cutaneous 11 Lymphoma, T-Cell, Peripheral 10 Hematologic Diseases 10 Sezary Syndrome 9 Mycosis Fungoides 9 Lymphoma, T-Cell 8 Leukemia, Myelomonocytic, Chronic 8 Immunoglobulin Light-chain Amyloidosis 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7

Interventions

Paclitaxel 3 Carboplatin 2 poly(I).poly(c12,U) 1 pembrolizumab 1 mirabegron 1 liposomal doxorubicin 1 disitamab vedotin 1 apatinib 1 anlotinib 1 Tocotrienols 1 Platinum Compounds 1 Lenalidomide 1 Interferon alpha-2 1 Hyperthermic Intraperitoneal Chemotherapy 1 EP-100 membrane-disrupting peptide 1 Cisplatin 1 Bevacizumab 1 AC 7700 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01111903 2016-03-17

REV

ARCAGY/ GINECO GROUP

Phase 1/2 Completed

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡